Recruiting studies: Oligoprogressive Prostate Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PSMA PET-Guided Progression-Directed Radiotherapy for Oligoprogressive Prostate Cancer
Phase N/A · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07691697 The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)
Phase 2 · 2 location(s) · University Medical Center Groningen · NCT07038304 Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
Phase 3 · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06585007 Stereotactic Magnetic Resonance Guided Radiation Therapy
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT04115254 Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer
NA · 1 location(s) · Sunnybrook Health Sciences Centre · NCT04838899 Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
NA · 1 location(s) · University of California, Davis · NCT06101290 Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT06927635

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.